AzTrials
AzTrials

Trauma PatientsNCT07530432

Analysis of Influencing Factors for the Development of PTSD in Emergency Department Trauma Patients

An observational study of Trauma Patients and PTSD, run by The First Affiliated Hospital of Air Force Medical University.

Not yet recruiting

Opening soon. The study is approved but enrolment has not started yet. Sites may already take enquiries.

Sites and contacts
Official record
Search all trials

Trial summary

The goal of this observational study is to learn about the long-term effects of key factors such as cognitive flexibility, social support, and physiological stress on the occurrence of Post-Traumatic Stress Disorder (PTSD) in adult trauma patients treated in the emergency department. Read more about this study

Who is it for?
Ages 18 to 65 years
Conditions the study is for
Trauma Patients, PTSD
How many people
250 participants
Where
No sites listed yet
Study dates
20 Mar 2026to Dec 2026
How long will I take part?
6 Months
Phase
Observational
Are there results?
Not yet: the study is under way

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 18 to 65 years
  • All sexes
  • No healthy volunteers
  • Adult, Older adult

Study population: This study is a single-center, prospective cohort study that plans to enroll a total of 250 adult trauma patients. The study subjects will be trauma patients seeking treatment at the Emergency Department of Xijing Hospital from January 2026 to December 2026.

Who may be able to join

  • Age between 18 and 65 years old (inclusive);
  • Experienced a life-threatening major traumatic event, clearly diagnosed by a clinician;
  • The patient is able to communicate normally with medical staff through language;
  • The subject is fully informed and voluntarily signs the informed consent form.

Who cannot join

  • History of psychiatric disorders or current use of psychotropic medications;
  • Pre-existing cognitive impairment (e.g., dementia, Alzheimer's disease);
  • Terminal illnesses (such as advanced malignant tumors, end-stage organ failure, advanced neurological diseases, or any other condition judged by the attending physician to have a life expectancy of less than 6 months);
  • Inability to cooperate with follow-up.

Trial locations and contacts

No sites are listed yet. Contact the study team or a site near you to ask about taking part.

yang li, Master's Student contact

+86 18089193316

li18089193316@163.com

About this study

The goal of this observational study is to learn about the long-term effects of key factors such as cognitive flexibility, social support, and physiological stress on the occurrence of Post-Traumatic Stress Disorder (PTSD) in adult trauma patients treated in the emergency department. The main question it aims to answer is:

Among emergency department patients who have experienced major trauma, can factors such as early post-trauma cognitive flexibility, level of social support, inflammatory markers, and trauma severity predict the development of PTSD within 6 months? Participants will complete a series of online questionnaires and clinical assessments at baseline, 1 month, 3 months, and 6 months after the traumatic event.

Medical subject headings
Stress Disorders, Post-Traumatic

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. PTSD Incidence as Assessed by the PTSD Checklist for DSM-5 (PCL-5)

    Number of participants with a total score ≥33 on the PCL-5 (range 0-80, higher scores indicate more severe PTSD symptoms) at 6 months after the traumatic event, indicating probable post-traumatic stress disorder (PTSD).

    Measured: 6 months post-trauma

Secondary outcomes (1)
  1. Association of Sociodemographic, Trauma-Related, and Psychosocial Factors with PTSD Status

    Odds ratios (ORs) and 95% confidence intervals for the association of each candidate factor (e.g., age, sex, injury severity score [ISS], social support [SSRS score], anxiety/depression [HADS score], cognitive flexibility [CFI score], inflammatory biomarkers [IL-6, CRP]) with probable PTSD status at 6 months, as determined by multivariable logistic regression.

    Measured: Baselin and 6 months post-trauma

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted15 Apr 2026
  2. Study start20 Mar 2026 (estimated)
  3. Primary completionDec 2026 (estimated)
  4. Study completionDec 2026 (estimated)

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Observational
Observational model
Cohort
Time perspective
Prospective
Enrolment
250 participants (estimated)
Target duration
6 Months
IDs, dates and publications
ClinicalTrials.gov ID
NCT07530432
Sponsor's protocol ID
KY20252601-F-1
Status last verified
Dec 2025
First submitted
19 Mar 2026
Last updated
15 Apr 2026
Results posted
No
Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
Individual data sharing
No

Questions about this trial

What is this clinical trial studying?

An observational study of Trauma Patients and PTSD, run by The First Affiliated Hospital of Air Force Medical University.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 4 inclusion and 4 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: opening soon, as of the sponsor's last update on 15 Apr 2026. Status can change between updates, so confirm with the study contact before making plans.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

This study is still under way. Results are not available in the source record yet.

How can a doctor refer a patient or contact the research team?

Contact yang li, Master's Student (+86 18089193316, li18089193316@163.com), or a site near the patient. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

PTSD Incidence as Assessed by the PTSD Checklist for DSM-5 (PCL-5) (time frame: 6 months post-trauma). It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 15 Apr 2026.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in